MedTrace Logo

Macrophage Migration Inhibitory Factor for Diagnosing Endometriosis and Its Severity

NCT04091997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-09-19

No results posted yet for this study

Summary

Endometriosis is a chronic disease affecting women of reproductive age. Macrophage migration inhibitory factor (MIF) is one of non-invasive blood biomarker that was detected in sera of endometriotic patients.The aim of this study was to evaluate the value of serum macrophage migration inhibitory factor in diagnosing endometriosis in women with infertility and chronic pelvic pain and correlate its level with the stage of the disease. Three hundred patient candidate for diagnostic laparoscopy were included in a case-control observational study

Conditions

  • Endometriosis

Interventions

DIAGNOSTIC_TEST

serum Eliza assay

laparoscopy and biopsy of lesions in endometriotic patients and seum ELIZA assay of microphage migration inhibitory factor

Sponsors & Collaborators

  • Fayoum University Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-09-30
Completion
2018-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091997 on ClinicalTrials.gov